Yefan Zhang Zhen Huang
10.3389/fphar.2023.1122885
Front Pharmacol
2023 May 23;14:1122885.
case report gastrointestinal stromal tumor (gist) late-line treatment refractory gist ripretinib combination therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/37288114/
Case Reports
PMC10242384
37288114
Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointestinal stromal tumors: two case reports and literature review
2023